Loading...
Loading...
India's clonazepam imports from NETHERLANDS total $785 across 2 shipments from 1 foreign suppliers. PHARMA MODUS LIMITED leads with $785 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include GRACURE PHARMACEUTICALS LIMITED. This corridor reflects India's pharmaceutical import demand for clonazepam — a concentrated sourcing relationship with select suppliers from NETHERLANDS.

PHARMA MODUS LIMITED is the leading Clonazepam supplier from NETHERLANDS to India, with import value of $785 across 2 shipments. The top 5 suppliers — PHARMA MODUS LIMITED — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PHARMA MODUS LIMITED | $785 | 2 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | GRACURE PHARMACEUTICALS LIMITED | $785 | 2 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Clonazepam suppliers from NETHERLANDS to India include PHARMA MODUS LIMITED. The leading supplier is PHARMA MODUS LIMITED with import value of $785 USD across 2 shipments. India imported Clonazepam worth $785 USD from NETHERLANDS in total across 2 shipments.
India imported Clonazepam worth $785 USD from NETHERLANDS across 2 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Clonazepam sourced from NETHERLANDS include GRACURE PHARMACEUTICALS LIMITED. The largest buyer is GRACURE PHARMACEUTICALS LIMITED with $785 in imports across 2 shipments.
The total value of Clonazepam imports from NETHERLANDS to India is $785 USD, across 2 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists